HomeRLMD • NASDAQ
add
Relmada Therapeutics Inc
Previous close
$1.52
Day range
$1.46 - $1.60
Year range
$0.24 - $3.98
Market cap
52.77M USD
Avg Volume
1.15M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.22M | -45.69% |
Net income | -9.87M | 44.47% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 20.62M | -70.73% |
Total assets | 21.12M | -70.27% |
Total liabilities | 5.17M | -45.82% |
Total equity | 15.95M | — |
Shares outstanding | 33.19M | — |
Price to book | 3.17 | — |
Return on assets | -104.74% | — |
Return on capital | -133.12% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -9.87M | 44.47% |
Cash from operations | -6.40M | 51.73% |
Cash from investing | 6.68M | -52.34% |
Cash from financing | -73.02K | — |
Net change in cash | 203.64K | -72.89% |
Free cash flow | -6.36M | 55.72% |
About
Founded
2004
Headquarters
Website
Employees
17
